Literature DB >> 12531364

Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives.

Francesco Sala1, M Manuela Rigano, Alessandra Barbante, Barbara Basso, Amanda M Walmsley, Stefano Castiglione.   

Abstract

Stable integration of a gene into the plant nuclear or chloroplast genome can transform higher plants (e.g. tobacco, potato, tomato, banana) into bioreactors for the production of subunit vaccines for oral or parental administration. This can also be achieved by using recombinant plant viruses as transient expression vectors in infected plants. The use of plant-derived vaccines may overcome some of the major problems encountered with traditional vaccination against infectious diseases, autoimmune diseases and tumours. They also offer a convenient tool against the threat of bio-terrorism. State of the art, experimental strategies, safety and perspectives are discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531364     DOI: 10.1016/s0264-410x(02)00603-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity.

Authors:  Marina Clemente; Roberto Curilovic; Alina Sassone; Alicia Zelada; Sergio O Angel; Alejandro N Mentaberry
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

2.  Functional Nitrogenase Cofactor Maturase NifB in Mitochondria and Chloroplasts of Nicotiana benthamiana.

Authors:  Xi Jiang; Diana Coroian; Emma Barahona; Carlos Echavarri-Erasun; Rocío Castellanos-Rueda; Álvaro Eseverri; Jose A Aznar-Moreno; Stefan Burén; Luis M Rubio
Journal:  mBio       Date:  2022-06-13       Impact factor: 7.786

Review 3.  Plant-based oral vaccines: results of human trials.

Authors:  C O Tacket
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 4.  Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.

Authors:  Susan A Brooks
Journal:  Mol Biotechnol       Date:  2004-11       Impact factor: 2.695

5.  Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs.

Authors:  Chul Han An; Salik Nazki; Sung-Chul Park; Yu Jeong Jeong; Ju Huck Lee; Su-Jin Park; Amina Khatun; Won-Il Kim; Youn-Il Park; Jae Cheol Jeong; Cha Young Kim
Journal:  Planta       Date:  2018-01-08       Impact factor: 4.116

Review 6.  Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals.

Authors:  Penelope Amelia Claire Sparrow; Judith A Irwin; Phil J Dale; Richard M Twyman; Julian K C Ma
Journal:  Transgenic Res       Date:  2007-02-07       Impact factor: 2.788

7.  Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco.

Authors:  Igor Kolotilin; Angelo Kaldis; Bert Devriendt; Jussi Joensuu; Eric Cox; Rima Menassa
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 8.  Plant-made vaccines in support of the Millennium Development Goals.

Authors:  Claire A Penney; David R Thomas; Sadia S Deen; Amanda M Walmsley
Journal:  Plant Cell Rep       Date:  2011-01-18       Impact factor: 4.570

9.  An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.

Authors:  Karina A Pasquevich; Andrés E Ibañez; Lorena M Coria; Clara García Samartino; Silvia M Estein; Astrid Zwerdling; Paula Barrionuevo; Fernanda S Oliveira; Christine Seither; Heribert Warzecha; Sergio C Oliveira; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

10.  Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate.

Authors:  Min-Kyoung Shin; Myung Hwan Jung; Won-Jung Lee; Pil Son Choi; Yong-Suk Jang; Han Sang Yoo
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.